Balance Sheet Components - Narrative (Details) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
May 03, 2026 |
May 04, 2025 |
Feb. 01, 2026 |
|
| Intangible Asset, Finite-Lived [Line Items] | |||
| Depreciation and amortization | $ 38,800,000 | $ 30,300,000 | |
| Intangible assets amortization expense | 2,000,000.0 | 4,000,000.0 | |
| Goodwill | 365,075,000 | $ 365,075,000 | |
| Impairments to goodwill | $ 0 | $ 0 | |
| Technology patents | |||
| Intangible Asset, Finite-Lived [Line Items] | |||
| Useful life (in years) | 2 months 12 days | ||
| Developed technology | |||
| Intangible Asset, Finite-Lived [Line Items] | |||
| Useful life (in years) | 2 months 12 days | ||
| Customer relationships | |||
| Intangible Asset, Finite-Lived [Line Items] | |||
| Useful life (in years) | 1 year 4 months 24 days | ||
| X | ||||||||||
- Definition Weighted-average period of amortization for finite-lived intangible asset acquired in business combination, asset acquisition, and from joint venture formation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|